Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -2.452\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CSc1nc2c(C)c(C)c(C)c(C)c2[nH]1
b CCc1c(C)sc(NC(=O)c2ccc(Br)o2)c1C(=O)OC
c Cc1cnc(C(=O)OCC(=O)Nc2cccc(Cl)c2)cn1
d CCC(c1nnnn1C1CCCC1)N1CCN(c2ccccc2F)CC1
e c1ccc(CNc2ncnc3sccc23)cc1
Answer: d. CCC(c1nnnn1C1CCCC1)N1CCN(c2ccccc2F)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(c1nnnn1C1CCCC1)N1CCN(c2ccccc2F)CC1
CCC(c1nnnn1C1CCCC1)N1CCN(c2ccccc2F)CC1
1-[1-(4-cyclopentyltetrazol-5-yl)propyl]-4-(2-fluorophenyl)piperazine